In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors ...

(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.

TomoCredit, the financial wellness platform that helps immigrants and underserved groups get access to essential credit, released today these practical tips on how to use the latest AI technology to ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

It also plans to collect an additional $17 million through a private placement of stock to investors at Wellington Management, which signed on to back the company in a venture capital round last fall.

Dexcom CEO Kevin Sayer gave an update on the company’s first over-the-counter glucose sensor and plans to expand coverage of devices for people with Type 2 diabetes. Boston Scientific CEO Mike Mahoney ...

In YouTuber Madilyn Bailey’s acoustic cover of Adele’s “Love in the Dark,” the powerhouse singer wields perfect mic placement—she stays close enough for detail but far enough to avoid ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dexcom CEO Kevin Sayer shared new data on the company’s first over-the-counter glucose sensor at the J.P ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from Leerink Partners maintained a Buy rating on the ...

Dexcom CEO Kevin Sayer shared new data on the company’s first over-the-counter glucose sensor at the J.P. Morgan Healthcare Conference on Monday. Stelo, which is indicated for people who don’t take ...